Differential Association of Programmed Death-1 and CD57 with Ex Vivo Survival of CD8+ T Cells in HIV Infection

Overview of attention for article published in The Journal of Immunology, July 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

patent: 11 patents

Readers on

mendeley: 90 Mendeley

So far, Altmetric has seen 11 patents that reference this research output.

COMBINATIONS OF CHECKPOINT INHIBITORS AND THERAPEUTICS TO TREAT CANCER

Application EP-4461372-A2

European Patent Office

13 Nov 2024

PROGRAMMED CELL DEATH 1 (PD1) SPECIFIC NUCLEASES

Application EP-4234570-A2

European Patent Office

30 Aug 2023

T cell modifying compounds and uses thereof

Grant US-11236175-B2

United States of America

01 Feb 2022

T CELL MODIFYING COMPOUNDS AND USES THEREOF

Application EP-3763810-A2

European Patent Office

13 Jan 2021

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 7 additional patents.